A 28-year-old woman with known HIV infection (CD4 count 85 cells/µL) presents with acute dyspnea, fever, and chest pain. Chest X-ray is normal. She is suspected of having Pneumocystis jirovecii pneumonia (PCP). What is the most appropriate next investigation to confirm the diagnosis?

## Confirmatory Investigation for PCP in Advanced HIV **Key Point:** Bronchoscopy with bronchoalveolar lavage (BAL) and immunofluorescence staining (or Giemsa/Wright-Giemsa stain) is the gold standard for confirming *Pneumocystis jirovecii* pneumonia (PCP), especially when clinical suspicion is high and non-invasive tests are inconclusive. ### Why BAL is Superior in This Case **Sensitivity and specificity:** - **BAL with immunofluorescence:** >95% sensitivity and specificity for PCP - **Sputum induction:** Only 50–80% sensitivity; lower yield in advanced immunosuppression - **Direct visualization:** Allows assessment of airway involvement and exclusion of other opportunistic infections (CMV, mycobacteria, fungi) ### Diagnostic Algorithm for Suspected PCP ```mermaid flowchart TD A["Suspected PCP<br/>CD4 < 200 cells/µL"]:::outcome --> B{"CXR findings?"}:::decision B -->|Normal or minimal findings| C["Sputum induction<br/>with Giemsa staining"]:::action B -->|Bilateral interstitial infiltrates| D["High clinical suspicion"]:::outcome C --> E{"Positive?"}:::decision E -->|Yes| F["Diagnose PCP"]:::outcome E -->|No| G["Proceed to BAL"]:::action D --> G G --> H["BAL with immunofluorescence"]:::action H --> I["Definitive diagnosis"]:::outcome ``` ### Comparison of Diagnostic Methods | Method | Sensitivity | Specificity | Invasiveness | Turnaround | Use Case | |---|---|---|---|---|---| | **CXR (standard)** | 75–85% | High | Non-invasive | Immediate | Screening; normal CXR does NOT exclude PCP | | **CXR (prone/expiratory)** | 85–90% | High | Non-invasive | Immediate | Improves detection of early/subtle infiltrates | | **HRCT (prone)** | 95–98% | High | Non-invasive | Minutes | Excellent for detecting early PCP; may show ground-glass opacities | | **Sputum induction** | 50–80% | High | Minimally invasive | 24 hrs | First-line in resource-limited settings; lower yield in advanced immunosuppression | | **BAL + immunofluorescence** | >95% | >95% | Invasive | 24 hrs | **Gold standard**; allows concurrent diagnosis of other infections | **Clinical Pearl:** In this patient with CD4 < 100 cells/µL, normal CXR does NOT exclude PCP. Up to 10–15% of PCP cases present with normal or near-normal chest imaging. BAL is indicated when clinical suspicion is high despite negative or equivocal non-invasive imaging. **High-Yield:** PCP prophylaxis is indicated when CD4 < 200 cells/µL (typically with TMP-SMX). If this patient is not on prophylaxis, PCP is a likely diagnosis and BAL confirmation is essential before starting therapy. **Mnemonic:** **BAL-IF** = **B**ronchoscopy **A**lveolar **L**avage with **I**mmunofluorescence = gold standard for PCP.